Shire is dedicated to enabling people with life-altering conditions to lead better lives by delivering innovative medicines to patients who need them. Shire’s commitment to clinical research goes beyond developing innovative medicine. We recognize that providing clinical trial data to patients, healthcare providers, independent researchers and the public will improve public confidence in medicine and help all stakeholders make better healthcare decisions.
Shire follows the Principles for Responsible Clinical Trial Data Sharing that were jointly adopted by the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Our pledge is to responsibly share clinical study data in a manner that is consistent with the following principles:
- Safeguarding the privacy of patients,
- Preserving scientific rigor and trust in regulatory systems, and
- Maintaining incentives for investments in biomedical research.
Read our Scope of Policy.
Shire discloses clinical trial information for medications on publicly available websites at a number of points, including: at the time of patient recruitment, within one year of study completion, after marketing authorization and when investigational research programs have been discontinued. To view results for Shire sponsored clinical trials visit Find a Study. Certain Clinical Study Report (CSR) synopses from Baxalta, now a part of Shire, studies can be found Here. These synopses provide a short overview of the purpose and results of the clinical trials.
Click on the links below to see what Shire is doing to support these data sharing principles: